SPIA
LJPC

Steward Partners Investment Advisory’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Steward Partners Investment Advisory’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-36
Closed – – 2845
2020
Q1 		$0 Hold
36
– – ﹤0.01% 2852
2019
Q4 		$0 Hold
36
– – ﹤0.01% 2889
2019
Q3 		$0 Buy
+36
New +$340 ﹤0.01% 2897

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Steward Partners Investment Advisory's LJPC Position: Q2 2020 in Review

Steward Partners Investment Advisory sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 36 shares.

Steward Partners Investment Advisory first reported a position in LJPC in Q3 2019 and held it in 3 quarters. The position peaked at $0 in Q1 2020. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Steward Partners Investment Advisory reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 36 La Jolla Pharmaceutical Company shares in Q2 2020.
  • Steward Partners Investment Advisory first reported a position in La Jolla Pharmaceutical Company in Q3 2019 and held it in 3 quarters.
  • Steward Partners Investment Advisory's La Jolla Pharmaceutical Company position peaked at $0 in Q1 2020.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2020, filed 6 Aug 2020.